您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [美股财报]:Ingevity Corp 2026年季度报告 - 发现报告

Ingevity Corp 2026年季度报告

2026-07-30 美股财报 苏吃吃
报告封面

FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACTOF 1934 For the quarterly period ended June30, 2026OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACTOF 1934 Commission File Number: 001-37586__________________________________________________________________________ (State or other jurisdiction of incorporation or organization) (Zip code) 843-740-2300(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d)of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filing requirements for the past 90days.YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that registrant was required to submit such files).YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerginggrowth company.See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule12b-2 of theExchange Act. If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correctionof an error to previously issued financial statements. Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’sexecutive officers during the relevant recovery period pursuant to §240.10D-1(b). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the Registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).Yes☐No The registrant had34,377,922shares of common stock,$0.01par value, outstanding atJuly24, 2026. Ingevity CorporationINDEX PART I - FINANCIAL INFORMATION3Item 1. Financial Statements3Condensed Consolidated Statements of Operations3Condensed Consolidated Statements of Comprehensive Income (Loss)4Condensed Consolidated Balance Sheets5Condensed Consolidated Statements of Cash Flows6Notes to the Condensed Consolidated Financial Statements7Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations34Item 3. Quantitative and Qualitative Disclosures About Market Risk48Item 4. Controls and Procedures49PART II - OTHER INFORMATION50Item 1. Legal Proceedings50Item 1A. Risk Factors50Item 2. Unregistered Sales of Equity Securities and Use of Proceeds51Item 3. Defaults Upon Senior Securities51Item 4. Mine Safety Disclosures51Item 5. Other Information51Item 6. Exhibits52SIGNATURES53 PART I - FINANCIAL INFORMATION INGEVITY CORPORATION Condensed Consolidated Statements of Operations (Unaudited) The accompanying notes are an integral part of these financial statements. INGEVITY CORPORATION The accompanying notes are an integral part of these financial statements. INGEVITY CORPORATION Condensed Consolidated Balance Sheets (Unaudited) INGEVITY CORPORATION Condensed Consolidated Statements of Cash Flows (Unaudited) Six Months Ended June 30, In millions Supplemental cash flow information: INGEVITY CORPORATIONNotes to the Condensed Consolidated Financial StatementsJune30, 2026(Unaudited) Note 1: Background Description of Business Ingevity Corporation ("Ingevity," "the company," "we," "us," or "our") provides products and technologies that purify,protect, and enhance the world around us. Through a diverse team of talented and experienced people, we develop, manufacture, andbring to market solutions that are largely renewably sourced and help customers solve complex problems while making the worldmore sustainable.Our products are used in a variety of demanding applications, including automotive gasoline vapor emissions controlsystems, food, water and chemical filtration, asphalt paving, agrochemical dispersants, bioplastics, coatings, and elastomers.Weoperate inthree reportable segments: Performance Materials, Pavement Technologies, and Advanced Polymer Technologies. Reportable Segment Renaming During 2026, dispositions within our former Performance Chemicals reportable segment resulted in a change to the segment'sname. Historically, our Performance Chemicals reportable segment consisted of the pave